Cannabinoids Document Safety Seed-To-Sale 
Cannabis Law Report
JANUARY 20, 2022
The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as directed by HB 3000 (2021). Delta-8 THC and other Artificially Derived Cannabinoids. Artificially Derived Cannabinoids Allowed in SOME Situations.
Medicinal Genomics
JANUARY 22, 2019
Medicinal Genomics Corporation (MGC), a pioneer in using genomics to improve the transparency, safety and yield of cannabis has today announced the industry’s most comprehensive Cannabis reference genome, a high quality de novo genome assembly of the Jamaican Lion cannabis strain.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 11, 2021
Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. cannabinoid hemp and hemp extract.”
Cannabis Law Report
OCTOBER 6, 2021
Flora will conduct thorough due diligence and honor the traditional FDA and NHS route in scientific processes to ensure consistency, quality, and delivery of cannabinoids for specific disease conditions, backed by data, with an initial focus on fibromyalgia, brain health, pain, and related research.
Cannabis Law Report
SEPTEMBER 10, 2022
The Oregon legislative Task Force on Cannabis-Derived Intoxicants and Illegal Cannabis Production is exploring potential reforms to the state’s regulation of cannabinoid products and legislation for 2023 to combat what law enforcement believes is an increase in illicit marijuana production. concentration threshold.
Cannabis Law Report
FEBRUARY 17, 2022
Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. Among the actions required under the quarantine order, ACK Natural, LLC was directed to immediately post the document to all public entrances of its establishment. PRESS RELEASE.
Cannabis Law Report
DECEMBER 21, 2019
The CEO of Folium Biosciences, Kashif Shan, is accused of violating a cease and desist order issued by the Colorado Spring fire department who had attempted to shut down the company’s CBD extraction plant because a host of regulations and safety codes were being ignored by the company and its senior management team. Full Spectrum CBD.
Expert insights. Personalized for you.
52 
Let's personalize your content